Home Federal Bank of Tennessee’s AbbVie ABBV Stock Holding History

Home Federal Bank of Tennessee’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.34M	Buy	17,227 +173	+1%	+$37.2K	0.94%	14
2026 Q1	$3.71M	Sell	17,054 -234	-1%	-$51.9K	0.93%	16
2025 Q4	$3.95M	Sell	17,288 -55	-0.3%	-$12.5K	1.03%	13
2025 Q3	$4.02M	Sell	17,343 -104	-0.6%	-$21.2K	1.07%	14
2025 Q2	$3.24M	Buy	17,447 +78	+0.4%	+$14.5K	0.92%	17
2025 Q1	$3.64M	Sell	17,369 -152	-0.9%	-$29.5K	1.08%	14
2024 Q4	$3.11M	Sell	17,521 -500	-3%	-$91.9K	0.92%	16
2024 Q3	$3.56M	Buy	18,021 +326	+2%	+$60.8K	1.02%	14
2024 Q2	$3.04M	Sell	17,695 -10	-0.1%	-$1.66K	0.92%	16
2024 Q1	$3.22M	Sell	17,705 -25	-0.1%	-$4.31K	1%	16
2023 Q4	$2.75M	Sell	17,730 -50	-0.3%	-$7.29K	0.92%	17
2023 Q3	$2.65M	Sell	17,780 -20	-0.1%	-$2.94K	0.98%	16
2023 Q2	$2.4M	Buy	17,800 +275	+2%	+$40.3K	0.85%	19
2023 Q1	$2.79M	Sell	17,525 -10	-0.1%	-$1.53K	1.04%	15
2022 Q4	$2.83M	Sell	17,535 -85	-0.5%	-$13K	1.08%	15
2022 Q3	$2.37M	Sell	17,620 -65	-0.4%	-$9.33K	0.99%	17
2022 Q2	$2.71M	Buy	17,685 +180	+1%	+$27.5K	1.06%	15
2022 Q1	$2.84M	Sell	17,505 -154	-0.9%	-$22.4K	0.97%	15
2021 Q4	$2.39M	Sell	17,659 -120	-0.7%	-$14.2K	0.79%	22
2021 Q3	$1.92M	Buy	17,779 +55	+0.3%	+$6.29K	0.69%	26
2021 Q2	$2M	Sell	17,724 -1,177	-6%	-$133K	0.72%	27
2021 Q1	$2.04M	Buy	18,901 +89	+0.5%	+$9.52K	0.77%	25
2020 Q4	$2.02M	Buy	18,812 +229	+1%	+$22K	0.8%	24
2020 Q3	$1.63M	Sell	18,583 -75	-0.4%	-$7.06K	0.72%	28
2020 Q2	$1.83M	Buy	18,658 +16	+0.1%	+$1.41K	0.85%	24
2020 Q1	$1.42M	Sell	18,642 -210	-1%	-$17.9K	0.77%	28
2019 Q4	$1.67M	Sell	18,852 -125	-0.7%	-$10.4K	0.7%	29
2019 Q3	$1.44M	Buy	18,977 +90	+0.5%	+$6.17K	0.65%	31
2019 Q2	$1.37M	Sell	18,887 -13	-0.1%	-$1.02K	0.63%	32
2019 Q1	$1.52M	Sell	18,900 -75	-0.4%	-$6.14K	0.72%	31
2018 Q4	$1.75M	Sell	18,975 -250	-1%	-$22K	0.92%	24
2018 Q3	$1.82M	Buy	19,225 +5	+0%	+$474	0.84%	28
2018 Q2	$1.78M	Sell	19,220 -1,280	-6%	-$125K	0.86%	25
2018 Q1	$1.94M	Sell	20,500 -450	-2%	-$49.4K	0.98%	22
2017 Q4	$2.03M	Sell	20,950 -713	-3%	-$67.2K	0.99%	22
2017 Q3	$1.93M	Sell	21,663 -192	-0.9%	-$14.6K	0.98%	21
2017 Q2	$1.58M	Hold	21,855	–	–	0.85%	28
2017 Q1	$1.42M	Buy	21,855 +277	+1%	+$17.4K	0.77%	29
2016 Q4	$1.35M	Sell	21,578 -375	-2%	-$22.9K	0.76%	30
2016 Q3	$1.39M	Sell	21,953 -100	-0.5%	-$6.47K	0.81%	28
2016 Q2	$1.36M	Buy	22,053 +15	+0.1%	+$914	0.82%	25
2016 Q1	$1.26M	Buy	22,038 +2,180	+11%	+$122K	0.79%	29
2015 Q4	$1.18M	Buy	+19,858	New	+$1.14M	0.77%	30

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Home Federal Bank of Tennessee's ABBV Position: Q2 2026 in Review

Home Federal Bank of Tennessee increased its AbbVie (ABBV) stake by 1% in Q2 2026, buying an estimated $37.2K and bringing the position to 17,227 shares worth $4.34M. The position accounts for 0.94% of the portfolio, ranked #14.

Home Federal Bank of Tennessee first reported a position in ABBV in Q4 2015 and has held it in 43 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Home Federal Bank of Tennessee held 17,227 shares of AbbVie worth $4.34M as of Q2 2026.
Home Federal Bank of Tennessee bought 173 AbbVie shares in Q2 2026, an estimated $37.2K.
AbbVie made up 0.94% of Home Federal Bank of Tennessee's portfolio in Q2 2026, its #14 holding.
Home Federal Bank of Tennessee first reported a position in AbbVie in Q4 2015 and has held it in 43 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Home Federal Bank of Tennessee's 13F filing for Q2 2026, filed 15 Jul 2026.